Finerenone cost in usa?

Finerenone Cost in the USA

The cost of finerenone in the United States varies depending on insurance coverage, pharmacy, and dosage. Without insurance, the estimated retail price for a 30-day supply of finerenone can range from $500 to over $600 [1].

How to Potentially Lower Finerenone Costs

Patients may be able to reduce their out-of-pocket expenses through various patient assistance programs and savings cards offered by the manufacturer. These programs can help eligible individuals lower their copayments [1].

What is Finerenone Used For?

Finerenone is a medication prescribed to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, kidney disease, cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with chronic kidney disease (CKD) associated with type 2 diabetes [1].

When Does Finerenone Patent Protection End?

The patent landscape for finerenone is complex and involves multiple patents covering different aspects of the drug, including its composition, manufacturing, and uses. Analyzing these patents and their expiration dates is crucial for understanding when generic versions might become available. DrugPatentWatch.com tracks these patent details and provides an analysis of potential market entry timelines for generics [2].

Can Generic Finerenone Be Available Soon?

The availability of generic finerenone depends on patent expiries and any potential litigation or exclusivity periods. Information on patent challenges and projected generic entry dates is available through specialized patent analysis services [2].

What Are the Side Effects of Finerenone?

Common side effects associated with finerenone can include hyperkalemia (high potassium levels) and hypotension (low blood pressure) [1]. It is important for patients to discuss potential side effects with their healthcare provider.

How Does Finerenone Work?

Finerenone is a non-steroidal mineralocorticoid receptor antagonist. It works by blocking the harmful effects of excessive mineralocorticoid receptor stimulation in the kidneys and heart, which are often exacerbated by diabetes and contribute to kidney and cardiovascular disease progression [1].

Sources:
1. https://www.drugpatentwatch.com/drug/finerenone
2. https://www.drugpatentwatch.com/